Ferroptosis and glaucoma: implications in retinal ganglion cell damage and optic nerve survival

Glaucoma and visual pathway degeneration: Glaucoma is the leading cause of irreversible blindness worldwide, which leads to a progressive loss of vision. Glaucoma can be classified into two types: primary open-angle glaucoma and primary closed-angle glaucoma. Primary openangle glaucoma can be caused by the blockage of the trabecular meshwork, and this results in elevation of the intraocular pressure (IOP), leading to retinal ganglion cell (RGC) death. However, many glaucoma patients have normal IOP; this is known as normal-tension glaucoma. Nevertheless, excitotoxic damage and oxidative stress can also lead to RGC damage in normal-tension glaucoma (Almasieh et al., 2012). Glaucomatous genes such as TIGR, OPTN, and CYP1B1 have been suggested to contribute to the pathogenesis of glaucoma. However, some glaucomatous patients may remain asymptomatic in the early, moderate, and late stages. Another type of glaucoma is primary closed-angle glaucoma. In this clinical condition, a relative pupillary block is contributed by the iris obstructing aqueous outflow. The patients may suffer from corneal swelling, headache, nausea, and blurred vision during the acute phase.

[1]  Sijia Song,et al.  Proteomics analysis of N-methyl-d-aspartate-induced cell death in retinal and optic nerves. , 2021, Journal of proteomics.

[2]  Y. Zhuo,et al.  Effects of Iron and Zinc on Mitochondria: Potential Mechanisms of Glaucomatous Injury , 2021, Frontiers in Cell and Developmental Biology.

[3]  Kellen L. Olszewski,et al.  DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer , 2021, Nature.

[4]  Zhen-Ni Guo,et al.  Ferroptosis in Neurological Diseases , 2020, Frontiers in Cellular Neuroscience.

[5]  Albert R. Bargoud,et al.  Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma. , 2020, Experimental eye research.

[6]  Xiu-ju Luo,et al.  Involvement of regulated necrosis in blinding diseases: Focus on necroptosis and ferroptosis. , 2020, Experimental eye research.

[7]  J. Olzmann,et al.  The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis , 2019, Nature.

[8]  Takatoshi Uchida,et al.  Role of Glutathione Peroxidase 4 in Glutamate-Induced Oxytosis in the Retina , 2015, PloS one.

[9]  C. To,et al.  Glutathione attenuates nitric oxide‐induced retinal lipid and protein changes , 2015, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[10]  Sophia Y. Wang,et al.  Association between serum ferritin and glaucoma in the South Korean population. , 2014, JAMA ophthalmology.

[11]  S. Snyder,et al.  Dexras1, a Small GTPase, Is Required for Glutamate-NMDA Neurotoxicity , 2013, The Journal of Neuroscience.

[12]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[13]  B. Morquette,et al.  The molecular basis of retinal ganglion cell death in glaucoma , 2012, Progress in Retinal and Eye Research.